CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer

Dong-Wan Kim, Hoon-Gu Kim, Joo-Hang Kim, Keunchil Park, Hoon-Kyo Kim, Joung Soon Jang, Bong-Seog Kim, Jin-Hyoung Kang, Kyung Hee Lee, Sang-We Kim, Hun Mo Ryoo, Jin-Soo Kim, Ki Hyeong Lee, Jung Hye Kwon, Jin-Hyuk Choi, Sang Won Shin, Seokyung Hahn, Dae Seog Heo

Cancer Research and Treatment. 2019;51(1):119-127. Published online 2018 March 12 DOI: https://doi.org/10.4143/crt.2018.019

Randomized Phase III Trial of Cisplatin/Irinotecan Versus Cisplatin/Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer

Primo N. Lara, David R. Gandara, Ronald B. Natale

Clinical Lung Cancer. 2006;7(5):353-356

Link1 Link2

Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

N.H. Hanna

Yearbook of Oncology. 2007;2007:214-216

Link1 Link2

1134 POSTER A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin in patients with extensive disease small cell lung cancer

European Journal of Cancer Supplements. 2005;3(2):327-328

Link1 Link2

Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer

Cancer Research and Treatment. 2019;51(1):119-127

Link1

Link2 Link3

Phase III randomized double blind placebo controlled trial of cisplatin(P) and etoposide (E) plus megestrol acetate (M)/placebo in extensive stage small cell lung cancer (SCLC)

Lung Cancer. 1994;11:90

Link1 Link2

Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer

I Sekine, H Nokihara, K Takeda, Y Nishiwaki, K Nakagawa, H Isobe, K Mori, K Matsui, N Saijo, T Tamura

British Journal of Cancer. 2008;98(4):693-696

Link1

Link2 Link3

Open-Label, Multicenter, Randomized, Phase III Study Comparing Oral Topotecan/Cisplatin Versus Etoposide/Cisplatin As Treatment for Chemotherapy-Naive Patients With Extensive-Disease Small-Cell Lung Cancer

N.H. Hanna

Yearbook of Oncology. 2007;2007:215-216

Link1 Link2

40 A phase II randomized trial of vinorelbine plus cisplatin ordocetaxel plus cisplatin in Inoperable, chemo-naïve non-small cell lung cancer patients

Y. Chen, J. Shih, C. Tsai, R. Perng, J. Whang-Peng

Lung Cancer. 2005;49:S389

Link1 Link2

Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: A randomized phase III study

Lung Cancer. 1995;12(1-2):146-147

Link1 Link2

Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer. Results of a prospective randomized FONICAP trial

Lung Cancer. 1991;7(3):203

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.